Prostaglandin E-major urinary metabolites as a new biomarker for acute mesenteric ischemia.

J Trauma Acute Care Surg

From the Department of Acute Critical Care and Disaster Medicine, Graduate School of Medical and Dental Sciences (K.S., K.M., T.A.), Department of Acute Critical Care and Disaster Medicine (A.S., K.N.), Tokyo Medical and Dental University Hospital of Medicine, Tokyo; Department of Acute Critical Care Medicine (K.S.), Tsuchiura Kyodo General Hospital, Tsuchiura, Ibaraki; Emergency and Critical Care Center (M.K.), Tokyo Women's Medical University Medical Center East, Tokyo, Japan; Trauma Unit, Department of Surgery, Faculty of Medicine (P.T.), Khon Kaen University, Khon Kaen, Thailand; Comparative Effectiveness and Clinical Outcomes Research Center-CECORC (R.C.), Riverside University Health System Medical Center, Moreno Valley, California; and National Hospital Organization Disaster Medical Center (Y.O.), Tokyo, Japan.

Published: June 2024

Background: Acute mesenteric ischemia (AMI) is an emergent vascular disease caused by cessation of the blood supply to the small intestine. Despite advances in the diagnosis, intervention, and surgical procedures, AMI remains a life-threatening condition. Prostaglandin E2 major urinary metabolite (PGE-MUM), the urinary metabolite of prostaglandin E2, is known to be stable in urine and has been suggested to be a valuable biomarker for intestinal mucosal inflammation, such as ulcerative colitis. We therefore investigated whether or not PGE-MUM levels reflect the degree of ischemia in an intestinal ischemia-reperfusion model.

Methods: Male rats were used to establish a superior mesenteric artery occlusion (SMAO) group, in which the superior mesenteric artery was clamped, and a sham group. The clamping times in the SMAO group were either 30 minutes or 60 minutes, and reperfusion times were either 3 hours or 6 hours, after which PGE-MUM values were measured.

Results: The histological injury score of the SMAO (30-minute ischemia and 6-hour reperfusion group, 1.8 ± 0.4; 60-minute ischemia and 6-hour reperfusion group, 4.7 ± 0.5) and were significantly greater than that of the sham group (0.4 ± 0.7, p < 0.05). The PGE-MUM levels in the SMAO group (30-minutes ischemia and 6-hour reperfusion group, 483 ± 256; 60-minutes ischemia and 6-hour reperfusion group, 889 ± 402 ng/mL) were significantly higher than in the sham group (30-minute and 6-hour observation group, 51 ± 20; 60-minute and 6-hour observation group, 73 ± 32 ng/mL; p < 0.05). Furthermore, the PGE-MUM value was corrected by the concentration of urinary creatinine (Cr). The PGE-MUM/urinary Cr levels in the SMAO group were also significantly higher than in the sham group ( p < 0.05).

Conclusion: We found that intestinal ischemia-reperfusion increased urinary PGE-MUM levels depending on the ischemic time. This suggests the potential utility of PGE-MUM as a noninvasive marker of intestinal ischemia.

Download full-text PDF

Source
http://dx.doi.org/10.1097/TA.0000000000004267DOI Listing

Publication Analysis

Top Keywords

smao group
16
sham group
16
ischemia 6-hour
16
6-hour reperfusion
16
reperfusion group
16
group
14
pge-mum levels
12
acute mesenteric
8
ischemia
8
mesenteric ischemia
8

Similar Publications

A family of -permethylindenyl-phenoxy (PHENI*) transition-metal chloride complexes has been synthesized and characterized (; {(η-CMe)Me(R″)Si(2-R-4-R'-CHO)}MCl; R,R' = Me, Bu, Cumyl (CMePh); R″ = Me, Pr, Ph; M = Ti, Zr, Hf). The ancillary chloride ligands could readily be exchanged with halides, alkyls, alkoxides, aryloxides, or amides to form PHENI* complexes [L]TiX (; X = Br, I, Me, CHSiMe, CHPh, NMe, OEt, ODipp). The solid-state crystal structures of these PHENI* complexes indicate that one of two conformations may be preferred, parametrized by a characteristic torsion angle (TA'), in which the η system is either disposed away from the metal center or toward it.

View Article and Find Full Text PDF

Prostaglandin E-major urinary metabolites as a new biomarker for acute mesenteric ischemia.

J Trauma Acute Care Surg

June 2024

From the Department of Acute Critical Care and Disaster Medicine, Graduate School of Medical and Dental Sciences (K.S., K.M., T.A.), Department of Acute Critical Care and Disaster Medicine (A.S., K.N.), Tokyo Medical and Dental University Hospital of Medicine, Tokyo; Department of Acute Critical Care Medicine (K.S.), Tsuchiura Kyodo General Hospital, Tsuchiura, Ibaraki; Emergency and Critical Care Center (M.K.), Tokyo Women's Medical University Medical Center East, Tokyo, Japan; Trauma Unit, Department of Surgery, Faculty of Medicine (P.T.), Khon Kaen University, Khon Kaen, Thailand; Comparative Effectiveness and Clinical Outcomes Research Center-CECORC (R.C.), Riverside University Health System Medical Center, Moreno Valley, California; and National Hospital Organization Disaster Medical Center (Y.O.), Tokyo, Japan.

Background: Acute mesenteric ischemia (AMI) is an emergent vascular disease caused by cessation of the blood supply to the small intestine. Despite advances in the diagnosis, intervention, and surgical procedures, AMI remains a life-threatening condition. Prostaglandin E2 major urinary metabolite (PGE-MUM), the urinary metabolite of prostaglandin E2, is known to be stable in urine and has been suggested to be a valuable biomarker for intestinal mucosal inflammation, such as ulcerative colitis.

View Article and Find Full Text PDF

A new family of zirconocene complexes of the type (Ind)ZrX (where Ind = CMeH and R = Me, Et and Ph) have been synthesised and fully characterised. Six new crystal structures have been reported (-(Ind)ZrBr, -(Ind)ZrCl, -(Ind)Zr(CHPh), -(Ind)Zr(CHPh), -(Ind)ZrBr and -(Ind)Zr(CHPh)). The complexes were studied for slurry-phase ethylene polymerisation when immobilised on solid polymethylaluminoxane (sMAO).

View Article and Find Full Text PDF

Vagus nerve stimulation modulates arachidonic acid production in the mesenteric lymph following intestinal ischemia-reperfusion injury.

J Trauma Acute Care Surg

October 2021

From the Department of Acute Critical Care and Disaster Medicine (K.N., Y.O.), Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University; Department of Acute Critical Care and Disaster Medicine (K.N., K.M., A.S., J.A., Y.O.), Tokyo Medical and Dental University Hospital of Medicine; Department of Biological Sciences (S.D., A.W., N.I., T.K.), Graduate School of Humanities and Sciences, Ochanomizu University, Tokyo; Emergency Medicine and Acute Care Surgery (M.Y.), Matsudo City General Hospital, Chiba; Emergency and Critical Care Center (M.K.), Tokyo Women's Medical University Medical Center East; Department of Comprehensive Pathology (K.Y.), Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan; and Department of Surgery (R.C.), Riverside University Health System Medical Center, Loma Linda University School of Medicine, Loma Linda, California.

Background: Inflammatory lipid mediators in mesenteric lymph (ML), including arachidonic acid (AA), are considered to play an important role in the pathogenesis of multiple-organ dysfunction after hemorrhagic shock. A previous study suggested that vagus nerve stimulation (VNS) could relieve shock-induced gut injury and abrogate ML toxicity, resulting in the prevention of multiple-organ dysfunction. However, the detailed mechanism of VNS in lymph toxicity remains unclear.

View Article and Find Full Text PDF

Effects of para-toluenesulfonamide intratumoral injection on non-small cell lung carcinoma with severe central airway obstruction: A multi-center, non-randomized, single-arm, open-label trial.

Lung Cancer

August 2016

State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China. Electronic address:

Background: Severe malignant airway obstruction (SMAO) is a life-threatening form of non-small cell lung carcinoma (NSCLC).

Objectives: To determine the efficacy and safety of para-toluenesulfonamide (PTS) intratumoral injection in NSCLC-SMAO.

Methods: Ninety patients with NSCLC-SAO received repeated courses of PTS intratumoral injection until tumor sizes had reduced by 50% or greater.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!